Biotech news for Tuesday, July 7, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Pharmaceutical company Medicure Inc. ( MCUJF ) announced that CFO Haaris Uddin has resigned from his position, effective July 24, 2026. Uddin is leaving the company to pursue a career opportunity in an unrelated industry. James Kinley, a current member of Medi…
Thomas Lohnes/Getty Images News COVID-19 vaccine maker BioNTech ( BNTX ) has conducted confidential discussions with prospective bidders regarding plans to shutter manufacturing locations in Germany, German business daily Handelsblatt reported. With its Q1 202…
Mdxhealth SA ( MDXH ) announced on Thursday that it received a Nasdaq notice for non-compliance after its shares failed to maintain a minimum $1 bid price for continued listing for 30 consecutive days. The notice does not impact the company's
Leading drugmakers traded higher on Thursday after the Trump administration proposed to reduce payment rates for drugs purchased under a federal program that benefits uninsured and low-income patients. The upsurge came after the Centers for Medicare & Medi…
Richard Drury Shares of Arcturus Therapeutics ( ARCT ) climbed on Thursday after the messenger RNA medicines company announced a partnership with Thermo Fisher Scientific ( TMO ) to advance ARCT-032, its experimental therapy for the genetic disorder cystic fib…
Propanc Biopharma ( PPCB ) has initiated a share repurchase program to buy back $5M shares. The company will buy a first tranche of up to $500,000 over the next 30-day period. PPCB +20.14% to $1.73. Source: Press Release More on Propanc Biopharma, Inc. Histori…
JHVEPhoto/iStock Editorial via Getty Images Roche ( RHHBY ) unit Genentech announced on Thursday its KRAS G12C inhibitor divarasib outperformed FDA-approved KRAS G12C inhibitors from Amgen ( AMGN ) and Bristol Myers Squibb ( BMY ) in a late-stage trial for pat…
Veronique D Biogen ( BIIB ) disclosed that its GAAP and non-GAAP financials for Q2 2026 will include a roughly $164M pre-tax charge attributed to acquisitions and collaborations completed during the period. As a result, the Alzheimer’s drugmaker projects nearl…
Abivax ( ABVX ) said the underwriters of its U.S. public offering have fully exercised their option to purchase an additional 960K American Depositary Shares (ADSs). With the overallotment option fully exercised, the offering will total 7.36M ADSs. The company…
United Therapeutics ( UTHR ) said it acquired privately held preclinical biotech Thymmune Therapeutics for $140M in cash, with potential earn-out payments of up to $160M tied to clinical and regulatory milestones through the end of 2031. The acquisition adds T…
Elicio Therapeutics ( ELTX ) priced a $15M registered direct offering led by two new fundamental institutional investors, with participation from an existing large shareholder. The clinical-stage biotechnology company agreed to sell about 4.38M shares of commo…
Just_Super/iStock via Getty Images The US FDA has approved Vertex Pharmaceuticals' ( VRTX ) gene therapy Casgevy (exagamglogene autotemcel) for children as young as two years old with sickle cell disease or β thalassemia. The approval is the eighth under the C…